- Home
- BMRN vs HAS Comparison
BMRN vs HAS Comparison
Compare BMRN & HAS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | BMRN | HAS |
|---|---|---|
| Founded | 1996 | 1923 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Recreational Games/Products/Toys |
| Sector | Health Care | Consumer Discretionary |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 10.5B | 11.1B |
| IPO Year | 1999 | N/A |
Fundamental Metrics
Financial Performance| Metric | BMRN | HAS |
|---|---|---|
| Price | $53.19 | $81.18 |
| Analyst Decision | Buy | Strong Buy |
| Analyst Count | 19 | 11 |
| Target Price | $88.42 | ★ $88.55 |
| AVG Volume (30 Days) | ★ 3.0M | 1.6M |
| Earning Date | 10-27-2025 | 10-23-2025 |
| Dividend Yield | N/A | ★ 3.45% |
| EPS Growth | ★ 59.53 | N/A |
| EPS | ★ 2.68 | N/A |
| Revenue | $3,094,001,000.00 | ★ $4,357,000,000.00 |
| Revenue This Year | $13.39 | $10.26 |
| Revenue Next Year | $7.57 | $6.23 |
| P/E Ratio | $19.92 | ★ N/A |
| Revenue Growth | ★ 12.39 | 0.79 |
| 52 Week Low | $50.76 | $49.00 |
| 52 Week High | $73.51 | $83.45 |
Technical Indicators
Market Signals| Indicator | BMRN | HAS |
|---|---|---|
| Relative Strength Index (RSI) | 46.19 | 59.01 |
| Support Level | $53.03 | $81.24 |
| Resistance Level | $54.66 | $83.38 |
| Average True Range (ATR) | 1.45 | 1.77 |
| MACD | -0.11 | 0.19 |
| Stochastic Oscillator | 31.61 | 73.01 |
Price Performance
Historical ComparisonAbout BMRN BioMarin Pharmaceutical Inc.
BioMarin is a global biotechnology company focused on developing and commercializing therapies for rare genetic diseases. BioMarin specializes in enzyme replacement therapies, gene therapies, and other advanced treatments designed to address complex genetic disorders. The company has eight approved therapies for conditions including achondroplasia, phenylketonuria, hemophilia, and mucopolysaccharidosis. BioMarin has an expanding, yet relatively early-stage, pipeline of treatments in development across skeletal conditions and enzyme therapies.
About HAS Hasbro Inc.
Hasbro is a branded play company providing children and families around the world with entertainment offerings based on a world-class brand portfolio. From toys and games to television programming, motion pictures, and a licensing program, Hasbro reaches customers by leveraging its well-known brands such as Transformers, Nerf, and Magic: The Gathering. The firm acquired EOne in 2019, bolting on popular family properties like Peppa Pig and PJ Masks, and since has divested noncore lines from the tie-up. Furthermore, the addition of Dungeons & Dragons Beyond in 2022, offers the firm access to 19 million digital tabletop players.